SUBSCribe
logo
twitterlinkedininstagramUser Profile
search
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • Spotlight Initiatives
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
        • Following The Culture Trail

          Amitabh Dube, country president of Novartis India, has travelled extensively, but it is his stay in Vietnam that he most fondly remembers, not just for its food, people and landscape but also for the footprints of Indian culture in the southeast Asian country

          Chitra Nair - July 29, 2023
        • Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?

          Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh

          V Keshavdev - December 10, 2020
        • A Growing Appetite

          Banking on acquisitions, Torrent Pharma is focused on strengthening its presence in the domestic market

          Krishna Gopalan - November 28, 2017
        • At Home With Art

          Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art

          Krishna Gopalan - August 19, 2017
        • Under The Weather - Part 2

          Even as it battles the US FDA, the industry has been caught off-guard by policy changes back home

          Krishna Gopalan - June 05, 2017
        • Under The Weather- Part 1

          The domestic pharma industry, which is already battling the US FDA, has now to contend with regulatory challenges at home

          Krishna Gopalan - May 20, 2017
        • Managing Growth 2017- Part 2

          Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal

          March 17, 2017
        • Making A Fresh Start

          CEOs from diverse sectors on what's in store for 2017

          March 17, 2017
        • Growth eclipse

          After a dream run, Sun Pharma is grappling with growth and regulatory issues. Can the country’s biggest drug maker rediscover its mojo?

          Krishna Gopalan - January 22, 2016
        • Cash-rich picks in the current market

          Looking for cash bargains? Here is a first cut list

          Jitendra Kumar Gupta - August 26, 2015